Category Specific RSS

Categories: Opinion

Is the value trade overbought?

A client asked earlier this week – is the value trade overbought? Our answer was yes but circling back with data/charts to which potentially support the assertion. Whilst we can talk to individual sector level valuations, in this email we provide 30,000 feet view of why the value to growth trade may take a pause here.

Chart #1 – Value equity positioning. Investor positioning in value vs growth is at its highest level in recent history. (Mind you a similar argument for Emerging Market investor positioning could also be made at the moment).

Chart #2 – U.S. Treasuries appear to be oversold. In the chart below, the top chart is the U.S. 10-yr Treasury yield and the bottom chart is RSI (relative strength index). The current RSI of 75.2 is suggesting oversold territory. The last time it was at these levels was in 1994 – the massive bond market sell-off driven by the U.S. Fed. We may start to see support for yields at these levels (or potential reversal…even if it is short-term), which will also work against the value trade.

Zach Riaz

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

2 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

4 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

4 weeks ago